Is Glycyrrhizin Powder effective for psoriasis?

Nov 24, 2025

Leave a message

David Zhao
David Zhao
As a quality assurance specialist, David ensures that every batch of botanical extracts meets cGMP standards and exceeds client expectations. His attention to detail is key to maintaining our reputation for purity and reliability.

Psoriasis affects over 125 million people worldwide - and many of them are actively searching for natural, science-backed solutions. Glycyrrhizin powder, a bioactive triterpenoid saponin extracted from Glycyrrhiza glabra (licorice root), has drawn serious attention from researchers and formulators alike. Multiple peer-reviewed studies now confirm that this compound targets several core mechanisms behind psoriatic inflammation. If you work in nutraceuticals, dermatology, or cosmetic formulation, understanding how glycyrrhizin works - and why it matters - could reshape your next product line.

 

What Is Glycyrrhizin Powder?

Glycyrrhizin (also called glycyrrhizic acid) is the primary bioactive compound in licorice root. It belongs to the oleanane-type pentacyclic triterpenoid saponin class. Structurally, it consists of:

  • An aglycone core - 18β-glycyrrhetic acid, a triterpenoid with anti-inflammatory activity
  • Two glucuronic acid units attached via a 1→2 glycosidic bond, which give the molecule water solubility

This dual structure is what makes glycyrrhizin powder so versatile. The triterpenoid core drives biological activity. The sugar moiety improves bioavailability and formulation compatibility.

In high-purity commercial form (≥75% or 99% HPLC), glycyrrhizin powder appears as a white crystalline powder with a characteristic sweet taste - roughly 50 times sweeter than sucrose by weight. It is used across pharmaceuticals, cosmetics, food, and dietary supplements.

 

How Does Glycyrrhizin Target Psoriasis at the Molecular Level?

Psoriasis is not simply a skin condition. It is a chronic immune-mediated inflammatory disease driven by dysregulated cytokine signaling, keratinocyte hyperproliferation, and T-cell activation. Glycyrrhizin addresses multiple points in this cascade simultaneously.

1. Suppression of the NF-κB Pathway

The NF-κB transcription factor sits at the center of psoriatic inflammation. When activated, it drives the production of TNF-α, IL-1β, and IL-6 - all key players in psoriatic plaques.

Glycyrrhizin directly inhibits NF-κB activation. A study published in Cellular Physiology and Biochemistry confirmed that glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin inflammation by interfering with the ERK/p38 MAPK and NF-κB signaling pathways in keratinocytes. This leads to measurable reductions in ICAM-1 expression and inflammatory cell infiltration.

2. Downregulation of IL-17A and Th17 Cell Activity

The IL-17 axis is now recognized as the dominant driver of psoriatic pathology. Th17 cells produce IL-17A, which triggers keratinocyte hyperproliferation and epidermal thickening.

A 2021 study in Frontiers in Pharmacology (PMC8161965) demonstrated that glycyrrhizin improved psoriasis by inhibiting IL-17A and IFN-γ expression both in vivo and in vitro. It also suppressed the proliferation of IL-17A-stimulated HaCaT keratinocytes. The researchers concluded that glycyrrhizin partially improves psoriasis pathogenesis through SIRT1-mediated STAT3 regulation.

3. Reduction of Th17 Differentiation in Clinical Settings

A 2015 clinical study published in PMC4659031 evaluated glycyrrhizin combined with acitretin in psoriasis patients. The results showed that the combination:

  • Significantly reduced Th17 cell differentiation
  • Lowered serum concentrations of IL-17, IL-22, and TNF-α
  • Improved PASI (Psoriasis Area and Severity Index) scores more effectively than acitretin alone

This is one of the few human clinical studies directly linking glycyrrhizin supplementation to measurable psoriasis improvement.

4. Inhibition of Pro-Inflammatory Cytokine Cascades

A 2023 study published in PLOS ONE tested glycyrrhizic acid compound ointment on imiquimod-induced psoriasis in mice. The findings were striking:

  • TNF-α, IL-12, and IL-17 secretion were all significantly reduced
  • Epidermal thickness decreased
  • Skin barrier integrity improved

The study concluded that glycyrrhizic acid compound ointment holds strong therapeutic potential for psoriasis management.

 

Glycyrrhizin Powder for Skin Formulations: What Formulators Need to Know

Beyond oral supplementation, glycyrrhizin powder has a well-established role in topical dermatological formulations. Here is what makes it particularly valuable for product developers:

  • Anti-inflammatory action - reduces redness, scaling, and irritation associated with psoriatic plaques
  • Tyrosinase inhibition - licorice flavonoids including isoliquiritigenin inhibit melanin production, making glycyrrhizin a dual-function ingredient for skin-brightening and anti-inflammatory formulas
  • Antioxidant activity - neutralizes reactive oxygen species that worsen psoriatic inflammation
  • Compatibility - water-soluble (via glucuronic acid residues), stable in emulsions, and compatible with most cosmetic actives
  • Regulatory acceptance - widely used in EU, US, and Asian cosmetic markets with an established safety profile

For B2B buyers, these properties translate directly into multi-claim product positioning - one ingredient that supports anti-inflammatory, brightening, and antioxidant claims simultaneously.

 

Key Research Summary: What the Evidence Actually Shows

Here is a clear breakdown of the current evidence base:

Study

Model

Key Finding

Qiong et al., 2021 (Front. Pharmacol.)

In vivo + in vitro

Glycyrrhizin inhibits IL-17A, IFN-γ; improves psoriasis via SIRT1/STAT3

Wu et al., 2015 (PMC4659031)

Human clinical trial

Glycyrrhizin + acitretin reduces Th17 cells and PASI scores

Zhang et al., 2023 (PLOS ONE)

Mouse model

Glycyrrhizic acid ointment reduces TNF-α, IL-12, IL-17

Karger study (Cell. Physiol. Biochem.)

Keratinocyte model

Glycyrrhizin blocks NF-κB and MAPK pathways

The evidence is consistent across multiple models - animal, cellular, and human. No single study is definitive, but the convergence of findings across independent research groups is compelling.

 

What B2B Buyers Should Look for in a Glycyrrhizin Powder Supplier

If you are sourcing glycyrrhizin powder for pharmaceutical, nutraceutical, or cosmetic manufacturing, specification quality is non-negotiable. Here are the critical checkpoints:

Purity & Assay

  • Minimum 75% glycyrrhizic acid by HPLC for pharmaceutical-grade applications
  • 99% specification available for high-potency cosmetic actives

Heavy Metal Compliance

  • Lead: <3 PPM
  • Arsenic: <1.5 PPM
  • Cadmium: <0.5 PPM
  • Mercury: <0.5 PPM

Microbial Safety

  • Total plate count: ≤1,000 CFU/g
  • Salmonella: Negative
  • E. coli: Negative

Certifications to Require

  • ISO 9001 and ISO 22000
  • cGMP and FSSC 22000
  • FDA-inspected facility
  • Halal and Kosher (for Middle East and specialty markets)
  • USDA/EU Organic (if organic positioning is needed)

A supplier who provides batch-specific COAs - not generic certificates - is the standard you should hold. Every shipment should come with documented assay results, heavy metal panels, and microbiology data.

 

Practical Dosage and Safety Considerations

Glycyrrhizin is pharmacologically active. That means dosage matters - both for efficacy and safety.

  • Topical applications: Concentrations of 0.1%–2% are typical in cosmetic formulations for anti-inflammatory and brightening effects
  • Oral supplementation context: Clinical studies have used glycyrrhizin in combination protocols; standalone oral dosing for psoriasis requires medical supervision
  • Safety note: High-dose or prolonged oral intake of glycyrrhizin can inhibit 11β-hydroxysteroid dehydrogenase, potentially causing pseudohyperaldosteronism (elevated blood pressure, fluid retention). This is a dose-dependent effect and well-documented in the literature.

For B2B formulation purposes, topical delivery carries a significantly lower systemic risk profile and aligns with the strongest available evidence for skin applications.

 

Why Glycyrrhizin Powder Belongs in Your Next Psoriasis-Focused Formula

The research picture is clear. Glycyrrhizin powder:

  • Hits multiple inflammatory targets - NF-κB, IL-17A, Th17 cells, TNF-α - rather than a single pathway
  • Works in both topical and systemic contexts, giving formulators flexibility
  • Carries a long safety history in traditional medicine and modern cosmetics
  • Offers multi-functional positioning - anti-inflammatory, antioxidant, and skin-brightening in one ingredient
  • Has regulatory acceptance across major global markets

For procurement managers, product developers, and formulators looking for a plant-derived active with genuine scientific backing, glycyrrhizin powder is one of the most well-supported options available today.

 

References

  1. Qiong H, et al. "Glycyrrhizin improves the pathogenesis of psoriasis partially through reversing the abnormal SIRT1-STAT3 signaling." Frontiers in Pharmacology, 2021; 12: 639932.
  2. Wu WZ, et al. "Glycyrrhizin combined with acitretin improve clinical symptom of psoriasis via reducing Th17 cell differentiation and related serum cytokine concentrations." International Journal of Clinical and Experimental Medicine, 2015; 8(10): 18915–18921.
  3. Zhang Y, et al. "The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis in mice." PLOS ONE, 2023; 18(8): e0290637.
  4. Rossi A, et al. "Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin inflammation by inhibiting ICAM-1 expression via interference with the ERK/p38 MAPK and NF-κB signaling pathways in keratinocytes." Cellular Physiology and Biochemistry, 2014; 35(4): 1335–1348.
  5. Fiore C, et al. "A history of the therapeutic use of liquorice in Europe." Journal of Ethnopharmacology, 2005; 99(3): 317–324.
  6. Yang R, et al. "Exploring the role of licorice and its derivatives in cell signaling pathway interactions for anti-inflammatory and antitumor activities." Evidence-Based Complementary and Alternative Medicine, 2024; Article ID 9988167.

 

Source Your Glycyrrhizin Powder with Confidence

At Jiuyuan Biotech, we supply pharmaceutical- and cosmetic-grade Glycyrrhizin Powder (≥75% and 99% HPLC) extracted from Glycyrrhiza glabra roots grown in China's Qinling Mountains. Our facility holds ISO 9001, ISO 22000, cGMP, FSSC 22000, FDA, Halal, Kosher, and USDA/EU Organic certifications. Every batch ships with a full COA covering assay, heavy metals, and microbiology.

MOQ starts at 1 kg. We serve buyers across North America, Europe, the Middle East, and Southeast Asia.

📧 Contact us: info@jiuybiotech.com 🌐 Product page: Glycyrrhizin Powder - Jiuyuan Biotech

Send Inquiry
Send Inquiry